Syprine Capsule
NDC 0187-2120
Product Information
Syprine (trientine hydrochloride) is a NDA-approved product labeled by Bausch Health Us Llc. This medication is used to treat a certain inherited disorder (Wilson's disease). It is supplied as a brown capsule for oral administration. This product entry covers the primary NDC 0187-2120 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
ATON;710;SYPRINE
Code Structure Chart
Product Details
What is NDC 0187-2120?
What are the uses of this product?
What are Active Ingredients of this product?
- TRIENTINE HYDROCHLORIDE 250 mg/1 - An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TRIENTINE HYDROCHLORIDE (UNII: HC3NX54582)
- TRIENTINE (UNII: SJ76Y07H5F) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GELATIN (UNII: 2G86QN327L)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 208720 - Syprine 250 MG Oral Capsule
- RxCUI: 208720 - trientine hydrochloride 250 MG Oral Capsule [Syprine]
- RxCUI: 313472 - trientine HCl 250 MG Oral Capsule
- RxCUI: 313472 - trientine hydrochloride 250 MG Oral Capsule
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.